• Link to Facebook
  • Link to X
  • Link to Youtube
  • Link to LinkedIn
  • Link to Bluesky Link to BlueskyLink to Bluesky
  • Link to Instagram
  • ESO
  • ESOC 2026
  • ESOC 2027
  • STROKE INSIGHTS
  • eSTEP
  • MEMBERSHIP
  • SUPPORT US
THE VOICE OF STROKE IN EUROPE
European Stroke Organisation
  • About
    • What we do
    • Who we are
      • Leadership
      • ESO Committees
      • Honorary Members
      • Award Recipients & Awards Selection Committee
      • Young Stroke Physicians and Researchers Committee
      • DEI Advisory Council
      • Head Office
    • Membership
      • Benefits
      • Individual Membership
      • Organisational Membership
      • Membership Fees
    • Governance
      • Bylaws and Statues, Advocacy
      • Code of Conduct
    • History
    • Global Stroke Cooperation
  • Meetings
    • ESO Conference
    • ICH Academy Meeting (IAM)
    • Simulation Workshop 2026
    • Winter School
    • Summer School
    • Edinburgh Stroke Research Workshop
    • European Stroke Science Workshop
    • Focused Workshop
    • Educational Webinars
    • ESO Endorsed Meetings and Education
      • Applications for Endorsement
    • Events Calendar
  • Guidelines
    • ESO Guideline Directory
    • ESO Guideline Board
    • ESO Guideline Development Webinar
  • Projects
    • ANGELS
    • ESO EAST (Enhancing and Accelerating Stroke Treatment)
    • RES-Q — Registry of Stroke Care Quality
    • EU Research Partnerships
    • QASC
    • Stroke Action Plan for Europe (SAP-E)
    • Stroke Unit and Stroke Centre Certification
    • WISE
  • Resources
    • eSTEP
    • Emerging Leader Programme
    • European Master Programme in Stroke Medicine
    • Department to Department Visit Programme
    • ESO Trials Alliance
    • European Telestroke Networks
    • COVID-19 Resources
    • Task Force 4 Ukraine
  • News and Media
    • European Stroke Journal (ESJ)
    • Blog
    • Podcast
    • Paper of the Month
    • Press
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ESOC 2023 Session Report – Neurointervention – Imaging and Reperfusion

25/05/2023/in ESO, ESOC /by Carine Legio

By Dr Zdravka Poljakovic

ESOC 2023 Session Report -Neurointervention – Imaging and Reperfusion

First lecture has been given by professor Joachim Fladt, from Canada, dealing with possible impact of brain atrophy/fraility on baseline stroke severity and outcome. Concept of brain fraility was an intriguing insight in brain reserve mechanisms where prof Fladt discussed cortical integrity and synaptic density. He presented the results of ESCAPE-NAI trial where an original way of combined analysis of brain fraility on non-contrast CT has been conducted. The features included global cortical atrophy scale, white matter hyperintensities, subcortical atrophy, lacunes and chronic infarcts in numbers. The results of the study clearly showed that brain fraility has impact on final outcome as well as cortical atrophy and chronic infarct burden. He stressed out that maybe more attention should be paid to the biological versus chronological brain age.

Dr Antje Schmidt Pogoda from Germany gave the next talk, which she herself described as provocative – what it really was. She analysed the problem of failure of neuroprotection  in clinical setting in contrast to the results of animal trials, and presented the possible explanation. According to it, lack of  infarct volume growth in clinical setting after stroke strongly influences the results of neuroprotection as this is the main measure of neuroprotection. According to this theory as infarct growth is the target of neuroprotection in experimental models, and most stroke patients do not experience infarct growth, in clinical setting we actually do not offer a target for neuroprotection.

Two lectures about special features and subgroup analysis from SELECT2 Imaging analysis were given by professor Amrou Saraj and gave a new insight into the study results as well as definitions of some neuroimaging characteristics in the study group of patients. The rational for this subanalysis were the facts that three RCT’s recently demonstrated improved functional outcomes after endovascular treatment (EVT) even in patients with large core, which extended EVT eligibility according to CT/MR-perfusion imaging. The hypothesis is therefore that ischemic core estimates on different imaging modalities correlates with EVT outcomes. However, important is to be aware of possibility of CTP over- and underestimation of ischemic core. So, the investigational group of prof Saraj concluded that ischemic core estimates demonstrated prognostic utility rather than treatment modification, that treatment effect maintained even in patients with very large core, and that reduced infarct growth was present in patients achieving functional independence and independent ambulation.

Next challenging presentation about MR Microscopy in Thrombectomy to assess clot composition given by professor Michael Breckwoldt showed the power of advanced neuroimaging techniques in clot analysis. Knowledge of clot histology may predict outcome or possible endovascular therapy resistance or recurrence of occlusion, or may give additional data about stroke etiology. The data about ex vivo MR microscopy of clots at 9.4 Tesla following thrombectomy already exist, and clot composition can be assessed by MR microscopy. Furthermore, white clots need more recanalization maneuvers, increased time to recanalization and have poorer clinical outcomes. So a preinterventional clot imaging can give valuable data about clot composition and might allow a personalized approach to thrombectomy, prof Breckwoldt  concluded.

Dr Jorge Pagola from Barcelona presented the results of a study about intracranial thrombus composition and possibilities of prediction early reoclussion accordingly. The study was inspired by the fact that certain percentage of patient experience early reoclusion, dr Pagola showed, and this fact has a huge impact on outcome of this patients.The possibility of prediction of this phenomena could be clinically important. According to the results of the study, rich B-lymphocite thrombus is an independent predictor of early unexpected reocclusion even after initial successful thrombectomy. On the other hand,  thromboinflammation is a potential therapeutic target that may decrease early reocclusion.

His collegue from Barcelona as well, dr Roger Collet Vidiella continued the session presenting interesting results of a RES-CAT study, namely clinical and angiographic outcomes after rescue stenting for failed mechanical thrombectomy. He showed the results of a metaanalysis of several studies which mainly showed that intracranial stent is a rescue therapy and that rescue stenting improves outcomes in failed thrombectomy. In the study he presented the group of investigators posed the same question, namely does rescue stenting improve the functional outcome of patients with failed mechanical thrombectomy. The results of the study showed a trend towards better functional outcome with rescue stenting, however, after adjustment this trend was not statistically significant. Furthermore, the results showed that patient with successful recanalization which was achieved after stenting have worse functional outcome in comparison with patients who did not need rescue stenting. However, a good news is that there were no issues in safety outcomes, he concluded.

Finally, professor Thanh N. Nguyen concluded the session with a talk about endovascular thrombectomy for patients with large vessel occlusion stroke beyond 24-hours. In summary of her talk she stated that good ASPECTS and collateral scores can serve as surrogates  for viable brain and slow infarct progression with good functional outcomes after 90.days. Interesting conclusion is by any means the fact that clinical-ASPECT mismatch paradigm can be a simple, more inclusive and more easily incorporated into clinical practice in comparison to perfusion-imaging mismatch paradigm and this approach can guide a therapeutic decision.

Recent Posts

  • Functional outcomes and quality of life after endovascular thrombectomy in large and extensive infarcts (ASPECTS 0–5): a multicentre registry study 13/11/2026
  • D2D Report – Michael Yirgalem Teka 06/11/2026
  • Train the Trainer workshop: learning to build our own stroke simulations 30/10/2026
  • Highlights from the 10th World Intracranial Hemorrhage Conference 23/10/2026
  • Beyond angiography: flat-panel imaging after thrombectomy 16/10/2026
  • D2D Report – Dimitar Mitsev 09/10/2026
  • The Expanding Role of Endovascular Therapy in Cerebral Venous Sinus Thrombosis 02/10/2026
  • ESJ Featured Article of the Month – September 2026: Anaesthesia during medium and distal vessel thrombectomy: a signal, not yet a strategy 25/09/2026
  • ESO TF4UKR D2D Report – Alina Trubetska 18/09/2026
  • Post-Stroke Complications 11/09/2026

Tags

2021 acute ischemic stroke brain cardiology career clinical D2D department to department visit emergency medicine ESJ ESO ESO-EAST ESOC ESOC 2018 ESOC 2019 ESOC 2022 ESOC 2023 ESOC 2024 ESOC 2025 ESOWSO2020 Europe European Stroke Journal FESO guidelines hospital interview ischaemic stroke ischemic stroke networking Neurology newsletter research SAFE stroke stroke care Stroke Center stroke in the young stroke research stroke treatment stroke trials TF4UKR TIA trials virtual YSPR

Archive

Categories

  • ESO
  • ESOC
  • IRT Post
  • Stroke Research

European Stroke Organisation
Reinacherstrasse 131
4053 Basel / Switzerland
E: esoinfo@eso-stroke.org

  • Home
  • ESO Conference
  • Blog
  • My ESO
  • Membership
  • Subscribe to our Newsletter
© ESO-STROKE 2024 — the Voice of Stroke in Europe
  • Link to Facebook
  • Link to X
  • Link to Youtube
  • Link to LinkedIn
  • Link to Bluesky Link to BlueskyLink to Bluesky
  • Link to Instagram
  • Imprint
  • Privacy Statement
  • Disclaimer
  • Contact
Scroll to top Scroll to top Scroll to top